Shares of RAPT Therapeutics, Inc. (RAPT) are down more than 9% Friday morning at $19.26.
The company today priced its public offering of 4,054,055 shares at $18.50 per share.
Gross proceeds of $75 million is estimated from the offering, which is expected to close on November 22.
RAPT has traded in the range of $9.85- $40.74 in the last 1 year.
Source: Read Full Article
Lates News:
-
Bitcoin Price Bounces Back To $26,000, Here's Why
-
1-800-FLOWERS.COM Rallies After Quarterly Earnings Beat Estimates
-
Satoshi-Era Bitcoin Whale Moves $1.2 Million Worth Of BTC After 13 Years
-
Cryptos Rise Amidst The Dollar's Retreat
-
Helen Of Troy Q1 Results Down, But Beats Estimates; Backs FY24 Outlook; Stock Up In Premarket